Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalyst Bio (NQ: CBIO )

5.830 USD +0.170 (+3.00%)
Official Closing Price Updated: 5:20 PM EDT, Oct 29, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 445,034
Open 5.730
Bid (Size) 5.120 (3)
Ask (Size) 6.160 (5)
Prev. Close 5.660
Today's Range 5.430 - 5.860
52wk Range 3.430 - 8.940
Shares Outstanding 11,935,169
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Catalyst Biosciences Receives US Patent for its Anti-Complement Factor 3 Portfolio of Engineered Proteases
CB 2782-PEG patent protection extended until at least 2038 
From GlobeNewswire News Releases
Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit
From GlobeNewswire News Releases

Performance

YTD
-10.31%
-10.31%
1 Month
+33.11%
+33.11%
3 Month
+13.76%
+13.76%
6 Month
-5.66%
-5.66%
1 Year
+3.55%
+3.55%

More News

Read More
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
From GlobeNewswire News Releases
Softlab9 Target Acquisition CleanGo GreenGo Signs Supply Agreement
From ACCESSWIRE
Catalyst Biosciences Reports Second Quarter 2020 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences Presents Data at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress
From GlobeNewswire News Releases
Catalyst Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
From GlobeNewswire News Releases
Catalyst Biosciences Added to Russell 2000 Index
From GlobeNewswire News Releases
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Appoints Charles Democko, Senior Vice President, Regulatory Affairs
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.